Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Successful Treatment-Free Remission After Ponatinib Discontinuation in Pretreated Patients with Chronic Myeloid Leukemia in Chronic Phase

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.11.003Source: DataRank Database

Successful Treatment-Free Remission After Ponatinib Discontinuation in Pretreated Patients with Chronic Myeloid Leukemia in Chronic Phase is a research paper published in Clinical Lymphoma Myeloma & Leukemia (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (20)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Koji Sasaki ORCID,Jayastu Senapati ORCID,Shimin Hu ORCID,Sara Dellasala,Ghayas C. Issa ORCID

Live enrichment

PubMed:39592322 PMC:PMC11911093

National Institutes of Health

Grant: P30CA016672

National Institutes of Health

Grant: CA100632

NCI NIH HHS

Grant: P50 CA100632

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39592322/

publisherhttps://api.elsevier.com/content/article/PII:S2152265024024030?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2152265024024030?httpAccept=text/plain

MeSH Terms

HumansLeukemia, Myeloid, Chronic-PhaseImidazolesPyridazinesProtein Kinase InhibitorsTreatment OutcomeRemission InductionRetrospective StudiesAdultAgedAged, 80 and overMiddle AgedFemaleMaleLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Keywords

ResistanceTyrosine kinase inhibitorCessationIntoleranceTfr